Myelomonocytic
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED) (NCT00109538) | Merck Sharp & Dohme LLC | 2005-05-01 |
Track Myelomonocytic automatically
Every clearance here is in the API, with alerts when new ones post.